Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses

Post-exposure vaccination with vaccinia virus (VACV) has been suggested to be effective in minimizing death if administered within four days of smallpox exposure. While there is anecdotal evidence for efficacy of post-exposure vaccination this has not been definitively studied in humans. In this stu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Holechek, Susan A., Denzler, Karen L., Heck, Michael C., Schriewer, Jill, Buller, R. Mark, Legrand, Fatema A., Verardi, Paulo H., Jones, Leslie A., Yilma, Tilahun, Jacobs, Bertram L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2013
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3798613/
https://ncbi.nlm.nih.gov/pubmed/24147092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0077879
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi